REQUEST A DEMO
Total
USD $0.00
Search more companies

Namyang Pharm Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Namyang Pharm Co.,Ltd. Profile Updated: November 04, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Namyang Pharm Co.,Ltd. is an enterprise in South Korea, with the main office in Seoul. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on July 01, 1990. There are currently 82 (2026) people employed by Namyang Pharm Co.,Ltd.. There was a net sales revenue increase of 10.7% reported in Namyang Pharm Co.,Ltd.’s latest financial highlights for 2025. Its’ total assets recorded a growth of 11.45%. The enterprise’s net profit margin decreased by 0.01% in 2025.

Headquarters
22, Yangpyeong-ro 30-gil Yeongdeungpo-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Namyang Pharm Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Namyang Pharm Co.,Ltd. report to view the information.
Incorporation Date:
July 01, 1990
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Subsidiaries
Tree Medical Co.,Ltd.
51%
C&N Medical Inc
New Shin Pharm Co.,Ltd.
Company Performance
Financial values in the chart are available after Namyang Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
10.7%▲
Total Operating Revenue
10.7%▲
Operating Profit
4.66%▲
EBITDA
4.13%▲
Net Profit/Loss for the Period
9.77%▲
Total Assets
11.45%▲
Total Equity
7.02%▲
Operating Profit Margin
-0.07%▼
Net Profit Margin
-0.01%▼
Return on Equity (ROE)
0.25%▲
Debt / Equity
10.62%▲
Quick Ratio
-0.04%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?